Loss of function or reduced LDLR number in the hepatocytes results in reduced clearance of plasma LDL and a 2- to 3-fold elevation in LDL cholesterol levels in heterozygous FH patients. This evidence concerns the gene LDLR and familial hyperaldosteronism.